• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆固醇耗竭导致癌细胞变硬,从而增强过继性 T 细胞免疫疗法。

Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy.

机构信息

Institute of Materials Science and Engineering, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Institute of Mechanical Engineering, EPFL, Lausanne, Switzerland.

出版信息

Nat Biomed Eng. 2021 Dec;5(12):1411-1425. doi: 10.1038/s41551-021-00826-6. Epub 2021 Dec 6.

DOI:10.1038/s41551-021-00826-6
PMID:34873307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7612108/
Abstract

Malignant transformation and tumour progression are associated with cancer-cell softening. Yet how the biomechanics of cancer cells affects T-cell-mediated cytotoxicity and thus the outcomes of adoptive T-cell immunotherapies is unknown. Here we show that T-cell-mediated cancer-cell killing is hampered for cortically soft cancer cells, which have plasma membranes enriched in cholesterol, and that cancer-cell stiffening via cholesterol depletion augments T-cell cytotoxicity and enhances the efficacy of adoptive T-cell therapy against solid tumours in mice. We also show that the enhanced cytotoxicity against stiffened cancer cells is mediated by augmented T-cell forces arising from an increased accumulation of filamentous actin at the immunological synapse, and that cancer-cell stiffening has negligible influence on: T-cell-receptor signalling, production of cytolytic proteins such as granzyme B, secretion of interferon gamma and tumour necrosis factor alpha, and Fas-receptor-Fas-ligand interactions. Our findings reveal a mechanical immune checkpoint that could be targeted therapeutically to improve the effectiveness of cancer immunotherapies.

摘要

恶性转化和肿瘤进展与癌细胞的软化有关。然而,癌细胞的生物力学如何影响 T 细胞介导的细胞毒性,从而影响过继性 T 细胞免疫疗法的结果,目前尚不清楚。在这里,我们表明,T 细胞介导的癌细胞杀伤受到皮质软癌细胞的阻碍,这些癌细胞的质膜富含胆固醇,而通过胆固醇耗竭使癌细胞变硬会增强 T 细胞的细胞毒性,并增强过继性 T 细胞疗法对小鼠实体瘤的疗效。我们还表明,针对变硬的癌细胞的增强的细胞毒性是通过免疫突触处丝状肌动蛋白的积累增加而导致的 T 细胞力的增强来介导的,并且癌细胞变硬对:T 细胞受体信号传导、细胞毒性蛋白如颗粒酶 B 的产生、干扰素 γ 和肿瘤坏死因子 α 的分泌以及 Fas 受体-Fas 配体相互作用几乎没有影响。我们的研究结果揭示了一种机械免疫检查点,可通过靶向治疗来提高癌症免疫疗法的有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/024b6b00bada/EMS137630-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/00444dbcb50a/EMS137630-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/0156037ff5ac/EMS137630-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/c8d77d0cb730/EMS137630-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/2b3d9e28980a/EMS137630-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/af1d01defc9c/EMS137630-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/662504b561e1/EMS137630-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/024b6b00bada/EMS137630-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/00444dbcb50a/EMS137630-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/0156037ff5ac/EMS137630-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/c8d77d0cb730/EMS137630-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/2b3d9e28980a/EMS137630-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/af1d01defc9c/EMS137630-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/662504b561e1/EMS137630-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba3/7612108/024b6b00bada/EMS137630-f007.jpg

相似文献

1
Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy.胆固醇耗竭导致癌细胞变硬,从而增强过继性 T 细胞免疫疗法。
Nat Biomed Eng. 2021 Dec;5(12):1411-1425. doi: 10.1038/s41551-021-00826-6. Epub 2021 Dec 6.
2
Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.黑色素瘤的免疫疗法:在疫苗诱导的抗肿瘤免疫与过继性免疫疗法中,干扰素-γ需求的二分法。
J Immunol. 2001 Jun 15;166(12):7370-80. doi: 10.4049/jimmunol.166.12.7370.
3
A Mechanical Immune Checkpoint Inhibitor Stiffens Tumor Cells to Potentiate Antitumor Immunity.一种机械性免疫检查点抑制剂使肿瘤细胞变硬以增强抗肿瘤免疫力。
Angew Chem Int Ed Engl. 2025 Jan 27;64(5):e202417518. doi: 10.1002/anie.202417518. Epub 2024 Nov 9.
4
Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy.靶向 METTL3 作为检查点以增强 T 细胞用于肿瘤免疫治疗。
Clin Transl Med. 2024 Nov;14(11):e70089. doi: 10.1002/ctm2.70089.
5
Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy.针对肿瘤血管生成的 TNF 可使效应 T 细胞靶向肿瘤,并增强免疫检查点阻断剂联合过继细胞治疗的疗效。
Clin Cancer Res. 2018 May 1;24(9):2171-2181. doi: 10.1158/1078-0432.CCR-17-2210. Epub 2018 Feb 28.
6
CD8 T cells regulate tumour ferroptosis during cancer immunotherapy.CD8 T 细胞在癌症免疫治疗中调节肿瘤铁死亡。
Nature. 2019 May;569(7755):270-274. doi: 10.1038/s41586-019-1170-y. Epub 2019 May 1.
7
Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.抗独特型抗体在人癌胚抗原转基因小鼠中诱导细胞免疫。
Immunology. 2006 Aug;118(4):483-96. doi: 10.1111/j.1365-2567.2006.02391.x.
8
A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.Fas 介导体外肿瘤杀伤在 T 细胞免疫治疗中的关键作用。
Cancer Discov. 2021 Mar;11(3):599-613. doi: 10.1158/2159-8290.CD-20-0756. Epub 2020 Dec 17.
9
Whole blood interferon-γ levels predict the therapeutic effects of adoptive T-cell therapy in patients with advanced pancreatic cancer.全血干扰素-γ 水平可预测晚期胰腺癌患者过继性 T 细胞治疗的疗效。
Int J Cancer. 2013 Sep 1;133(5):1119-25. doi: 10.1002/ijc.28117. Epub 2013 Mar 29.
10
Anti-tumour effect of neo-antigen-reactive T cells induced by RNA mutanome vaccine in mouse lung cancer.RNA 突变组疫苗诱导的新抗原反应性 T 细胞对小鼠肺癌的抗肿瘤作用。
J Cancer Res Clin Oncol. 2021 Nov;147(11):3255-3268. doi: 10.1007/s00432-021-03735-y. Epub 2021 Jul 21.

引用本文的文献

1
RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis.RNA结合蛋白DDX3X通过TLE2-MYL9轴驱动胰腺癌进展。
Sci Adv. 2025 Sep 12;11(37):eadw9519. doi: 10.1126/sciadv.adw9519.
2
Functional hydrogel for modulating lipid droplets and neuroinflammation in head injury.用于调节头部损伤中脂滴和神经炎症的功能性水凝胶。
Adv Funct Mater. 2025 Jul 4. doi: 10.1002/adfm.202507086.
3
Direct laser writing of electronically conductive microstructures within soft hydrogel substrates.在柔软水凝胶基质中直接激光写入导电微结构。

本文引用的文献

1
Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer.细胞毒性淋巴细胞靶向癌症特有的生物物理脆弱性。
Immunity. 2021 May 11;54(5):1037-1054.e7. doi: 10.1016/j.immuni.2021.02.020. Epub 2021 Mar 22.
2
Dendritic cell actin dynamics control contact duration and priming efficiency at the immunological synapse.树突状细胞肌动蛋白动力学控制免疫突触中的接触持续时间和启动效率。
J Cell Biol. 2021 Apr 5;220(4). doi: 10.1083/jcb.202006081.
3
Mechanical Immunoengineering of T cells for Therapeutic Applications.T 细胞的机械免疫工程用于治疗应用。
Mater Today Bio. 2025 Jul 30;34:102140. doi: 10.1016/j.mtbio.2025.102140. eCollection 2025 Oct.
4
Immunological synapse: structures, molecular mechanisms and therapeutic implications in disease.免疫突触:结构、分子机制及在疾病中的治疗意义
Signal Transduct Target Ther. 2025 Aug 11;10(1):254. doi: 10.1038/s41392-025-02332-6.
5
Nanotechnology for immuno-oncology.免疫肿瘤学的纳米技术
Nat Cancer. 2025 Aug 7. doi: 10.1038/s43018-025-01025-x.
6
Evaluating cholesterol de novo synthesis biomarkers: a systematic review and meta-analysis of cancer prognosis and clinical outcomes.评估胆固醇从头合成生物标志物:关于癌症预后和临床结局的系统评价与荟萃分析
BMC Cancer. 2025 Jul 24;25(1):1208. doi: 10.1186/s12885-025-14633-8.
7
Disrupting membranes, controlling cell fate: the role of pore-forming proteins in cell death and therapy.破坏细胞膜,控制细胞命运:成孔蛋白在细胞死亡和治疗中的作用
Apoptosis. 2025 Jul 21. doi: 10.1007/s10495-025-02133-w.
8
Targeting cancer cell stiffness and metastasis with clinical therapeutics.利用临床疗法靶向癌细胞硬度与转移
Clin Exp Metastasis. 2025 Jun 11;42(4):34. doi: 10.1007/s10585-025-10353-2.
9
Image-based evaluation of single-cell mechanics using deep learning.基于深度学习的单细胞力学图像评估。
Cell Regen. 2025 Jun 5;14(1):21. doi: 10.1186/s13619-025-00239-9.
10
Mechanoimmunological Control of Metastatic Site Selection.转移位点选择的机械免疫学控制
bioRxiv. 2025 May 13:2025.05.10.653256. doi: 10.1101/2025.05.10.653256.
Acc Chem Res. 2020 Dec 15;53(12):2777-2790. doi: 10.1021/acs.accounts.0c00486. Epub 2020 Dec 1.
4
Cell Softness Prevents Cytolytic T-cell Killing of Tumor-Repopulating Cells.细胞柔软性可防止细胞毒性T细胞杀伤肿瘤再增殖细胞。
Cancer Res. 2021 Jan 15;81(2):476-488. doi: 10.1158/0008-5472.CAN-20-2569. Epub 2020 Nov 9.
5
Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma.用于治疗青光眼的细胞软化胶束向施莱姆管内皮细胞的靶向递送
Small. 2020 Oct;16(43):e2004205. doi: 10.1002/smll.202004205. Epub 2020 Oct 4.
6
Mouse T cell priming is enhanced by maturation-dependent stiffening of the dendritic cell cortex.树突状细胞皮层成熟依赖性的硬度增加增强了小鼠 T 细胞的启动。
Elife. 2020 Jul 27;9:e55995. doi: 10.7554/eLife.55995.
7
Mechanosensing through YAP controls T cell activation and metabolism.通过 YAP 进行机械感知控制 T 细胞的激活和代谢。
J Exp Med. 2020 Aug 3;217(8). doi: 10.1084/jem.20200053.
8
Microparticle traction force microscopy reveals subcellular force exertion patterns in immune cell-target interactions.微颗粒牵引力显微镜揭示免疫细胞-靶细胞相互作用中的亚细胞力作用模式。
Nat Commun. 2020 Jan 7;11(1):20. doi: 10.1038/s41467-019-13804-z.
9
Mechanosensing through immunoreceptors.机械感受器通过免疫受体。
Nat Immunol. 2019 Oct;20(10):1269-1278. doi: 10.1038/s41590-019-0491-1. Epub 2019 Sep 18.
10
Mechanobiology of Macrophages: How Physical Factors Coregulate Macrophage Plasticity and Phagocytosis.巨噬细胞的生物力学:物理因素如何共同调节巨噬细胞的可塑性和吞噬作用。
Annu Rev Biomed Eng. 2019 Jun 4;21:267-297. doi: 10.1146/annurev-bioeng-062117-121224.